A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new ...

On January 7, 2025, the FDA issued a draft guidance called Considerations for the Use of Artificial Intelligence to Support Regulatory ...

Conduit is planning how to effectively integrate an advanced platform-driven approach powered by artificial intelligence and cybernetics to expedite drug development, while continuing to advance its ...

The artificial intelligence community is raving over a new reasoning model that has surprised even Silicon Valley.

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...

The survey also showed that high drug costs and artificial intelligence are topmost among the respondent’s concerns.

Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule candidates that target the cancer-driving KRAS protein, ...

Via AI methodologies, trial sponsors can simulate outcomes for different clinical development pathway scenarios to evaluate ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Strong IP protections will incentivize the human creativity that’s essential to improving, applying, and using AI.